What's breaking now, across thousands of outlets.
Genmab A/S shares surged the most in more than six years after its experimental ovarian cancer treatment exceeded analyst expectations in a late-stage trial, boosting confidence in the Danish drugmaker’s pipeline.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
In Switzerland, Thomas Rau offers treatments that many conventional doctors would question. Now he’s accused of lethally negligent care.
Health-e News Mother seeks justice eight years after alleged assault on daughter at Tshwane school A Soshanguve mother says her daughter suffered serious head injuries after allegedly being assaulted…
Nigeria’s Minister of Health has confirmed the evacuation of the country’s first imported Ebola patient from Abuja to Switzerland along with her spouse.
(RTTNews) - On Monday, BioNTech (BNTX) and DualityBiologics, subsidiary of Duality Biotherapeutics (9606.HK) said trastuzumab pamirtecan met the primary endpoint in the Phase 3 DYNASTY-Breast02 trial…
Ugandans returning from neighbouring Democratic Republic of Congo will be quarantined for 21 days, the health ministry has said, as the country tightens restrictions to contain the spread of Ebola…
Walmart is teaming up with startup General Medicine to expand its Better Care Services, turning the digital healthcare platform into a more comprehensive healthcare marketplace.
